Reprioritising global mental health: psychoses in sub-Saharan Africa

O O Omigbodun, G K Ryan, B Fasoranti, D Chibanda, R Esliker, A Sefasi, R Kakuma, T Shakespeare, J Eaton, O O Omigbodun, G K Ryan, B Fasoranti, D Chibanda, R Esliker, A Sefasi, R Kakuma, T Shakespeare, J Eaton

Abstract

Arthur Kleinman's 2009 Lancet commentary described global mental health as a "moral failure of humanity", asserting that priorities should be based not on the epidemiological and utilitarian economic arguments that tend to favour common mental health conditions like mild to moderate depression and anxiety, but rather on the human rights of those in the most vulnerable situations and the suffering that they experience. Yet more than a decade later, people with severe mental health conditions like psychoses are still being left behind. Here, we add to Kleinman's appeal a critical review of the literature on psychoses in sub-Saharan Africa, highlighting contradictions between local evidence and global narratives surrounding the burden of disease, the outcomes of schizophrenia, and the economic costs of mental health conditions. We identify numerous instances where the lack of regionally representative data and other methodological shortcomings undermine the conclusions of international research carried out to inform decision-making. Our findings point to the need not only for more research on psychoses in sub-Saharan Africa, but also for more representation and leadership in the conduct of research and in international priority-setting more broadly-especially by people with lived experience from diverse backgrounds. This paper aims to encourage debate about how this chronically under-resourced field, as part of wider conversations in global mental health, can be reprioritised.

Keywords: Global Mental Health; Human Rights; Psychosis; Sub-Saharan Africa.

Conflict of interest statement

The authors declare no competing interests.

© 2023. The Author(s).

References

    1. Kleinman A. Global mental health: a failure of humanity. The Lancet. 2009;374:603–604. doi: 10.1016/S0140-6736(09)61510-5.
    1. Patel V. Universal health coverage for schizophrenia: a global mental health priority. Schizophr Bull. 2015;42:885–890. doi: 10.1093/schbul/sbv107.
    1. Misra S, Stevenson A, Haroz EE, et al. ‘Global mental health’: systematic review of the term and its implicit priorities. BJPsych Open. 2019 doi: 10.1192/bjo.2019.39.
    1. World Bank Group. Out of the shadows: Making mental health a global priority, Accessed 6 May 2019.
    1. Wellcome Trust. Mental health: Transforming research and treatments, Accessed 14 May 2019.
    1. Wellcome Trust. Wellcome’s Vision and Strategy, Accessed 14 Feb 2023.
    1. The Lancet Psychiatry Mental health and COVID-19: change the conversation. Lancet Psychiatry. 2020 doi: 10.1016/S2215-0366(20)30194-2.
    1. Buckley PF, Miller BJ, Lehrer DS, et al. Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin. 2009 doi: 10.1093/schbul/sbn135.
    1. Ryan G, Iemmi V, Hanna F, et al. Mental health for sustainable development: a topic guide for development professionals. 2019. London and Brighton: K4D Emerging issues report. . Accessed 21 Mar 2023
    1. Funk M, Drew N, Freeman M. Mental Health and Development: Targeting people with mental health conditions as a vulnerable group. Mental Health and Poverty Project. Geneva: World Health Organisation; 2010.
    1. Funk M, Drew N, Knapp M. Mental health, poverty and development. J Public Ment Health. 2012;11:166–185. doi: 10.1108/17465721211289356.
    1. Morgan C, Dazzan P, Gureje O, et al. Announcing the lancet psychiatry commission on psychoses in global context. Lancet Psychiatry. 2021 doi: 10.1016/S2215-0366(21)00234-0.
    1. Cohen A, Patel V, Thara R, et al. Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophrenia Bulletin. 2008 doi: 10.1093/schbul/sbm105.
    1. Burns JK. The social determinants of schizophrenia: an African journey in social epidemiology. Public Health Rev. 2012;34:8. doi: 10.1007/BF03391676.
    1. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016 doi: 10.1016/s2215-0366(15)00505-2.
    1. Gureje O. Psychiatry in Africa: the myths, the exotic, and the realities. Aging Trends. 2007;10:11–14.
    1. Cooper S. Prising open the ‘black box’: An epistemological critique of discursive constructions of scaling up the provision of mental health care in Africa. Health. 2014;19:523–541. doi: 10.1177/1363459314556905.
    1. Mills C, Hilberg E. ‘Built for expansion’: the ‘social life’of the WHO's mental health GAP Intervention Guide. Sociol Health Illn. 2019;41:162–175. doi: 10.1111/1467-9566.12870.
    1. Perälä J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archiv General Psychiatry. 2007 doi: 10.1001/archpsyc.64.1.19.
    1. SUCCEED: Support, comprehensive care and empowerment of people with psychosocial disabilities in Sub-Saharan Africa, Accessed 15 June 2021.
    1. WHO. International Classification of Diseases, Eleventh Revision (ICD-11), Accessed 24 Jan 2023.
    1. Nelson JC, Bickford D, Delucchi K, et al. Risk of psychosis in recurrent episodes of psychotic and nonpsychotic major depressive disorder: a systematic review and meta-analysis. Am J Psychiatry. 2018;175:897–904. doi: 10.1176/appi.ajp.2018.17101138.
    1. Aminoff SR, Onyeka IN, Ødegaard M, et al. Lifetime and point prevalence of psychotic symptoms in adults with bipolar disorders: a systematic review and meta-analysis. Psychological Med. 2022 doi: 10.1017/S003329172200201X.
    1. NIMH. Understanding Psychosis. Bethesda, Maryland: National Institutes of Health. . Accessed 21 March 2023
    1. Parnas J, Nordgaard J, Varga S. The concept of psychosis: a clinical and theoretical analysis. Clin Neuropsychiatry. 2010;7:32–37.
    1. Van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry. 2016;15:118–124. doi: 10.1002/wps.20310.
    1. Kleinman A. Anthropology and psychiatry: the role of culture in cross-cultural research on illness. Br J Psychiatry. 1987;151:447–454. doi: 10.1192/bjp.151.4.447.
    1. Kirmayer LJ. Cultural variations in the response to psychiatric disorders and emotional distress. Soc Sci Med. 1989;29:327–339. doi: 10.1016/0277-9536(89)90281-5.
    1. Wolfers T, Doan NT, Kaufmann T, et al. Mapping the heterogeneous phenotype of schizophrenia and bipolar disorder using normative models. JAMA Psychiat. 2018;75:1146–1155. doi: 10.1001/jamapsychiatry.2018.2467.
    1. Liang SG, Greenwood TA. The impact of clinical heterogeneity in schizophrenia on genomic analyses. Schizophr Res. 2015 doi: 10.1016/j.schres.2014.11.019.
    1. Picardi A, Viroli C, Tarsitani L, et al. Heterogeneity and symptom structure of schizophrenia. Psychiatry Res. 2012;198:386–394. doi: 10.1016/j.psychres.2011.12.051.
    1. Coombes BJ, Markota M, Mann JJ, et al. Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores. Transl Psychiatry. 2020;10:314. doi: 10.1038/s41398-020-00996-y.
    1. Patel KR, Cherian J, Gohil K, et al. Schizophrenia: overview and treatment options. Pharmacy Therapeutics. 2014;39:638–645.
    1. Malhotra S. Acute and transient psychosis: a paradigmatic approach. Indian J Psychiatry. 2007 doi: 10.4103/0019-5545.37662.
    1. WHO. WHO Mental health gap action programme, Accessed 5 Feb 2015.
    1. Dua T, Barbui C, Patel AA, et al. Discussion of the updated WHO recommendations for mental, neurological, and substance use disorders. Lancet Psychiatry. 2016 doi: 10.1016/s2215-0366(16)30184-5.
    1. WHO . Guidelines for the management of physical health conditions in adults with severe mental disorders. Geneva: World Health Organisation; 2018.
    1. Dinishak J. The deficit view and its critics. Disability Stud Quarterly. 2016;36:112. doi: 10.18061/dsq.v36i4.5236.
    1. Murray C, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ. 1994;72:481.
    1. Murray C, Lopez A. The Global Burden of Disease. Cambridge: Harvard School of Public Health; 1996.
    1. Patel V, Prince M. Global mental health: a new global health field comes of age. JAMA. 2010;303:1976–1977. doi: 10.1001/jama.2010.616.
    1. Mills C. From ‘invisible problem’ to global priority: the inclusion of mental health in the sustainable development goals. Dev Chang. 2018;49:843–866. doi: 10.1111/dech.12397.
    1. Cosgrove L, Mills C, Karter JM, et al. A critical review of the Lancet Commission on global mental health and sustainable development: time for a paradigm change. Critical Pub Health. 2019 doi: 10.1080/09581596.2019.1667488.
    1. Freeman M. Global mental health in low and middle income, especially African countries. Epidemiol Psychiatric Sci. 2016 doi: 10.1017/S2045796016000482.
    1. Cooper RS, Osotimehin B, Kaufman JS, et al. Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet. 1998;351:208–210. doi: 10.1016/S0140-6736(97)06512-4.
    1. Parks R. The rise, critique and persistence of the DALY in global health. J Global Health Columbia Univ. 2014;4:28–32.
    1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. The lancet. 1997;349:1269–1276. doi: 10.1016/S0140-6736(96)07493-4.
    1. Ye Y, Wamukoya M, Ezeh A, et al. Health and demographic surveillance systems: a step towards full civil registration and vital statistics system in sub-Sahara Africa? BMC Public Health. 2012;12:741. doi: 10.1186/1471-2458-12-741.
    1. Mathers CD, Ma Fat D, Inoue M, et al. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171–177c.
    1. Brhlikova P, Pollock AM, Manners R. Global Burden of Disease estimates of depression–how reliable is the epidemiological evidence? J R Soc Med. 2011;104:25–34. doi: 10.1258/jrsm.2010.100080.
    1. Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2019 (GBD 2019) data input sources tool, Accessed 28 Oct 2020.
    1. Awas M, Kebede D, Alem A. Major mental disorders in Butajira, southern Ethiopia. Acta Psychiatr Scand. 1999;100:56–64. doi: 10.1111/j.1600-0447.1999.tb10695.x.
    1. Fekadu A, Medhin G, Kebede D, et al. Excess mortality in severe mental illness: 10-year population-based cohort study in rural Ethiopia. British J Psychiatry. 2015 doi: 10.1192/bjp.bp.114.149112.
    1. Kebede D, Alem A. Major mental disorders in Addis Ababa, Ethiopia I Schizophrenia, schizoaffective and cognitive disorders. Acta Psychiatrica Scandinavica. 1999;100:11–17. doi: 10.1111/j.1600-0447.1999.tb10688.x.
    1. Bondestam S, Garssen J, Abdulwakil AI. Prevalence and treatment of mental disorders and epilepsy in Zanzibar. Acta Psychiatr Scand. 1990;81:327–331. doi: 10.1111/j.1600-0447.1990.tb05458.x.
    1. Ben-Tovim DI, Cushnie JM. The prevalence of schizophrenia in a remote area of Botswana. Br J Psychiatry. 1986;148:576–580. doi: 10.1192/bjp.148.5.576.
    1. Moreno-Küstner B, Martín C, Pastor L. Prevalence of psychotic disorders and its association with methodological issues a systematic review and meta-analyses. PLOS ONE. 2018 doi: 10.1371/journal.pone.0195687.
    1. Simeone JC, Ward AJ, Rotella P, et al. An evaluation of variation in published estimates of schizophrenia prevalence from 1990–2013: a systematic literature review. BMC Psychiatry. 2015;15:193. doi: 10.1186/s12888-015-0578-7.
    1. Saha S, Chant D, Welham J, et al. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141. doi: 10.1371/journal.pmed.0020141.
    1. He H, Liu Q, Li N, et al. Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the global burden of disease study 2017. Epidemiol Psychiatric Sci. 2020 doi: 10.1017/S2045796019000891.
    1. Roberts T, Gureje O, Thara R, et al. INTREPID II: protocol for a multistudy programme of research on untreated psychosis in India Nigeria and Trinidad. BMJ Open. 2020 doi: 10.1136/bmjopen-2020-039004.
    1. Morgan C, Cohen A, Esponda GM, et al. Epidemiology of untreated psychoses in 3 diverse settings in the global south: the international research program on psychotic disorders in diverse settings (INTREPID II) JAMA Psychiat. 2023;80:40–48. doi: 10.1001/jamapsychiatry.2022.3781.
    1. WHO. Management of physical health conditions in adults with severe mental disorders: WHO guidelines. 2018. Geneva: World Health Organisation.
    1. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time. Archives General Psychiatry. 2007;64:1123–1131. doi: 10.1001/archpsyc.64.10.1123.
    1. Stubbs B, Koyanagi A, Veronese N, et al. Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries. BMC Med. 2016;14:189. doi: 10.1186/s12916-016-0734-z.
    1. Asher L, Fekadu A, Hanlon C. Global mental health and schizophrenia. Current Opinion Psychiatry. 2018;31:193–199. doi: 10.1097/YCO.0000000000000404.
    1. Liu NH, Daumit GL, Dua T, et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017;16:30–40. doi: 10.1002/wps.20384.
    1. HRW. "Like a Death Sentence": Abuses against Persons with Mental Disabilities in Ghana. Report no. 1-56432-945-3 2012. Human Rights Watch.
    1. MDAC and MHU. Psychiatric hospitals in Uganda: A human rights investigation. Report no. 978–615–80107–7–1, 2014. Mental disability advocacy centre mental health Uganda.
    1. Ayenew W, Asmamaw G, Bitew T. Antipsychotic Polypharmacy among patients with schizophrenia in Africa: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2021;11:123.
    1. Igbinomwanhia NG, Olotu SO, James BO. Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria. Therapeutic Adv Psychopharmacol. 2017;7:3–10. doi: 10.1177/2045125316672134.
    1. Borges G, Nock MK, Haro Abad JM, et al. Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. Journal Clin Psychiatry. 2010 doi: 10.4088/JCP.08m04967blu.
    1. Varshney M, Mahapatra A, Krishnan V, et al. Violence and mental illness: what is the true story? J Epidemiol Community Health. 2016;70:223. doi: 10.1136/jech-2015-205546.
    1. Stuart H. Violence and mental illness: an overview. World Psychiatry. 2003;2:121–124.
    1. Afe TO, Emedoh TC, Ogunsemi O, et al. Intimate partner violence, psychopathology and the women with schizophrenia in an outpatient clinic South-South. Nigeria BMC Psychiatry. 2016;16:197–197. doi: 10.1186/s12888-016-0898-2.
    1. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72:334–341. doi: 10.1001/jamapsychiatry.2014.2502.
    1. Whiteford HA, Ferrari AJ, Vos T. Challenges to estimating the true global burden of mental disorders. Lancet Psychiatry. 2016;3:402–403. doi: 10.1016/S2215-0366(16)30026-8.
    1. Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the global burden of disease study 2010. PloS ONE. 2014 doi: 10.1371/journal.pone.0091936.
    1. Adinkrah M. Anti-suicide laws in nine African countries: Criminalization, prosecution and penalization. African J Criminol Justice Stud. 2016;9:279.
    1. WHO . Schizophrenia: An international follow-up study. Chichester: Wiley; 1979.
    1. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures a World Health Organization Ten-Country Study. Psychol Med Monograph Suppl. 2009 doi: 10.1017/S0264180100000904.
    1. Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. British J Psychiatry. 2001 doi: 10.1192/bjp.178.6.506.
    1. Hopper K, Wanderling J. Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. Schizophr Bull. 2000;26:835–846. doi: 10.1093/oxfordjournals.schbul.a033498.
    1. Jääskeläinen E, Juola P, Hirvonen N, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013 doi: 10.1093/schbul/sbs130.
    1. Haro JM, Novick D, Bertsch J, et al. Cross-national clinical and functional remission rates: worldwide schizophrenia outpatient health outcomes (W-SOHO) study. British J Psychiatry. 2011 doi: 10.1192/bjp.bp.110.082065.
    1. Bolton P, Lee C, Haroz EE, et al. A transdiagnostic community-based mental health treatment for comorbid disorders: development and outcomes of a randomized controlled trial among burmese refugees in Thailand. PLOS Med. 2014 doi: 10.1371/journal.pmed.1001757.
    1. Szymczynska P, Walsh S, Greenberg L, et al. Attrition in trials evaluating complex interventions for schizophrenia: Systematic review and meta-analysis. J Psychiatr Res. 2017;90:67–77. doi: 10.1016/j.jpsychires.2017.02.009.
    1. Leucht S, Burkard T, Henderson J, et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007;116:317–333. doi: 10.1111/j.1600-0447.2007.01095.x.
    1. Kebede D, Alem A, Shibre T, et al. The sociodemographic correlates of schizophrenia in Butajira, rural Ethiopia. Schizophr Res. 2004 doi: 10.1016/s0920-9964(03)00089-6.
    1. Kebede D, Alem A, Shibre T, et al. Short-term symptomatic and functional outcomes of schizophrenia in Butajira Ethiopia. Schizophr Res. 2005 doi: 10.1016/j.schres.2005.05.028.
    1. Kebede D, Alem A, Shibre T, et al. Onset and clinical course of schizophrenia in Butajira-Ethiopia. Soc Psychiatry Psychiatr Epidemiol. 2003;38:625–631. doi: 10.1007/s00127-003-0678-4.
    1. Makanjuola RO, Adedapo SA. The DSM-III concepts of schizophrenic disorder and schizophreniform disorder a clinical and prognostic evaluation. British J Psychiatry. 1987 doi: 10.1192/bjp.151.5.611.
    1. Gureje O, Bamidele R. Thirteen-year social outcome among Nigerian outpatients with schizophrenia. Social Psychiatry Psychiatric Epidemiol. 1999 doi: 10.1007/s001270050126.
    1. Oosthuizen P, Emsley RA, Keyter N, et al. Duration of untreated psychosis and outcome in first-episode psychosis Perspective from a developing country. Acta Psychiatr Scand. 2005 doi: 10.1111/j.1600-0447.2004.00448.x.
    1. Lora A, Kohn R, Levav I, et al. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low-and middle-income countries. Bull World Health Organ. 2012;90:47–54B. doi: 10.2471/BLT.11.089284.
    1. Hailemariam M, Fekadu A, Prince M, et al. Engaging and staying engaged: a phenomenological study of barriers to equitable access to mental healthcare for people with severe mental disorders in a rural African setting. International J Equity Health. 2017;16:156. doi: 10.1186/s12939-017-0657-0.
    1. Iseselo MK, Ambikile JS. Medication challenges for patients with severe mental illness: experience and views of patients, caregivers and mental health care workers in Dar es Salaam, Tanzania. Int J Ment Heal Syst. 2017;11:1–12.
    1. Fekadu A, Kebede D, Alem A, et al. Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira. Ethiopia Acta Psychiatrica Scandinavica. 2006;114:426–434. doi: 10.1111/j.1600-0447.2006.00825.x.
    1. Vardi N. Another drug company that raises prices like crazy. Forbes. 2016;11:123.
    1. Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health. 2002;92:92–98. doi: 10.2105/ajph.92.1.92.
    1. Hanlon C, Medhin G, Selamu M, et al. Impact of integrated district level mental health care on clinical and social outcomes of people with severe mental illness in rural Ethiopia: an intervention cohort study. Epidemiol Psychiatric Sci. 2020;29:112. doi: 10.1017/S2045796019000398.
    1. Burns JK, Tomita A. Traditional and religious healers in the pathway to care for people with mental disorders in Africa: a systematic review and meta-analysis. Social Psychiatry Psychiatric Epidemiol. 2015 doi: 10.1007/s00127-014-0989-7.
    1. Gureje O, Lasebikan VO, Kola L, et al. Lifetime and 12-month prevalence of mental disorders in the Nigerian survey of mental health and well-being. British J Psychiatry. 2006 doi: 10.1192/bjp.188.5.465.
    1. Nortje G, Oladeji B, Gureje O, et al. Effectiveness of traditional healers in treating mental disorders: a systematic review. Lancet Psychiatry. 2016 doi: 10.1016/s2215-0366(15)00515-5.
    1. Burns J, Kirkbride J. Social capital, pathway to care and duration of untreated psychosis: findings from a low-and middle-income country context. S Afr J Psychiatry. 2012;18:163–170.
    1. Burns JK, Jhazbhay K, Emsley RA. Causal attributions, pathway to care and clinical features of first-episode psychosis: a South African perspective. Int J Soc Psychiatry. 2011;57:538–545. doi: 10.1177/0020764010390199.
    1. Ofori-Atta A, Attafuah J, Jack H, et al. Joining psychiatric care and faith healing in a prayer camp in Ghana: randomised trial. Br J Psychiatry. 2018;212:34–41. doi: 10.1192/bjp.2017.12.
    1. Gureje O, Appiah-Poku J, Bello T, et al. Effect of collaborative care between traditional and faith healers and primary health-care workers on psychosis outcomes in Nigeria and Ghana (COSIMPO): a cluster randomised controlled trial. Lancet. 2020 doi: 10.1016/S0140-6736(20)30634-6.
    1. Read UM. Between Chains and Vagrancy: Living with Mental Illness in Kintampo, Ghana. Doctoral thesis , UCL (University College London). 2012.
    1. Ghebrehiwet S, Baul T, Restivo JL, et al. Gender-specific experiences of serious mental illness in rural Ethiopia: a qualitative study. Glob Public Health. 2020;15:185–199. doi: 10.1080/17441692.2019.1680723.
    1. den Hertog TN, Gilmoor AR. Informal care for people with chronic psychotic symptoms: four case studies in a San community in South Africa. Health Soc Care Commun. 2017;25:538–547. doi: 10.1111/hsc.12339.
    1. Sibeko G, Milligan PD, Temmingh H, et al. Caregiving for mental health service users: a study exploring the perceptions of mental health service users and their caregivers in Cape Town, South Africa. Int J Soc Psychiatry. 2016;62:512–521. doi: 10.1177/0020764016651458.
    1. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum; 2011.
    1. Kessler RC, Amminger GP, Aguilar-Gaxiola S, et al. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20:359–364. doi: 10.1097/YCO.0b013e32816ebc8c.
    1. Abubakar A, Holding P, Mwangome M, et al. Maternal perceptions of factors contributing to severe under-nutrition among children in a rural African setting. Rural Remote Health. 2011;11:1–11.
    1. Harnois G, Gabriel P. Mental health and work: impact issues and good practices. Geneva: International Labour Organisation World Health Organisation; 2000.
    1. Tsang HW, Angell B, Corrigan PW, et al. A cross-cultural study of employers' concerns about hiring people with psychotic disorder: implications for recovery. Social Psychiatry Psychiatric Epidemiol. 2007 doi: 10.1007/s00127-007-0208-x.
    1. Amoo G, Ogunlesi A. Financial cost of treating Nigerian in-patients with schizophrenia. Afr J Med Med Sci. 2005;34:15–23.
    1. Suleiman TG, Ohaeri JU, Lawal RA, et al. Financial cost of treating out-patients with schizophrenia in Nigeria. Br J Psychiatry. 1997;171:364–368. doi: 10.1192/bjp.171.4.364.
    1. Chong HY, Teoh SL, Wu DB-C, et al. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016 doi: 10.2147/NDT.S96649.
    1. WHO . Mental Health Atlas 2017. Geneva: World Health Organisation; 2018.
    1. Chisholm D. Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organization. World Psychiatry. 2005;4:37–44.
    1. Chisholm D, Gureje O, Saldivia S, et al. Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis. Bulletin World Health Organ. 2008;86:542–551. doi: 10.1590/S0042-96862008000700014.
    1. Yang Y, Li W, Lok K-I, et al. Voluntary admissions for patients with schizophrenia: a systematic review and meta-analysis. Asian J Psychiatry. 2020 doi: 10.1016/j.ajp.2019.101902.
    1. Zanardo GLdP, Moro LM, Ferreira GS, et al. Factors associated with psychiatric readmissions: a systematic review. J Paidéia Ribeirão Preto. 2018 doi: 10.1590/1982-4327e2814.
    1. Donisi V, Tedeschi F, Wahlbeck K, et al. Pre-discharge factors predicting readmissions of psychiatric patients: a systematic review of the literature. BMC Psychiatry. 2016;16:449. doi: 10.1186/s12888-016-1114-0.
    1. Mwesiga EK, Nakasujja N, Nakku J, et al. One year prevalence of psychotic disorders among first treatment contact patients at the national psychiatric referral and teaching hospital in Uganda. Plos ONE. 2020 doi: 10.1371/journal.pone.0218843.
    1. Yussuf AD, Kuranga SA, Balogun OR, et al. Predictors of psychiatric readmissions to the psychiatric unit of a tertiary health facility in a Nigerian city—a 5-year study. Afr J Psychiatry. 2008 doi: 10.4314/ajpsy.v11i3.30267.
    1. Ezenduka C, Ichoku H, Ochonma O. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria. J Ment Health Policy Econ. 2012;15:139–148.
    1. Ryan GK, Kamuhiirwa M, Mugisha J, et al. Peer support for frequent users of inpatient mental health care in Uganda: Protocol of a quasi-experimental study. BMC Psychiatry. 2019;19:374.
    1. WHO and the Gulbenkian Global Mental Health Platform . Innovation in Deinstitutionalization: A WHO Expert Survey. Geneva: World Health Organization; 2014.
    1. Addo R, Agyemang SA, Tozan Y, et al. Economic burden of caregiving for persons with severe mental illness in sub-Saharan Africa: a systematic review. PloS ONE. 2018 doi: 10.1371/journal.pone.0199830.
    1. Addo R, Nonvignon J, Aikins M. Household costs of mental health care in Ghana. J Mental Health Policy Econ. 2013;16:151–159.
    1. Ohaeri JU. Caregiver burden and psychotic patients' perception of social support in a Nigerian setting. Soc Psychiatry Psychiatric Epidemiol. 2001;36:86–93. doi: 10.1007/s001270050294.
    1. Tirfessa K, Lund C, Medhin G, et al. Food insecurity among people with severe mental disorder in a rural Ethiopian setting: a comparative, population-based study. Epidemiol Psych Sci. 2019;28:397–407. doi: 10.1017/S2045796017000701.
    1. Weye N, Christensen MK, Momen NC, et al. The global burden of disease methodology has been good for mental disorders: but not good enough. Can J Psychiatry. 2020 doi: 10.1177/0706743719893591.
    1. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012 doi: 10.1016/S0140-6736(12)61680-8.
    1. Patel V, Cohen A, Thara R, et al. Is the outcome of schizophrenia really better in developing countries. Brazilian J Psychiatry. 2006;28:149. doi: 10.1590/S1516-44462006000200014.
    1. Kidder T. Mountains beyond Mountains: One doctor's quest to heal the world. New York: Random House; 2003.
    1. Davies R. Shekhar saxena: making mental health a development priority. Lancet. 2018;392:1509. doi: 10.1016/S0140-6736(18)32476-0.
    1. Weine S, Kohrt BA, Collins PY, et al. Justice for george floyd and a reckoning for global mental health. Global Mental Health. 2020 doi: 10.1017/gmh.2020.17.
    1. Bemme D, Kirmayer LJ. Global Mental Health: Interdisciplinary challenges for a field in motion. Transcult Psychiatry. 2020;57:3–18. doi: 10.1177/1363461519898035.
    1. Pan African Network of People with Psychosocial Disabilities. The Cape Town Declaration 16th October 2011. Disability and the Global South 2014 1: 385–386.
    1. Schneider M, Loeb M, Mirembe J. Collecting disability statistics: a participatory strategy? In: Hartley S, editor. Community-based rehabilitation (CBR) as a participatory strategy in Africa. Kampala: Uganda National Institute of Special Education; 2002.
    1. Keynejad R, Spagnolo J, Thornicroft G. WHO mental health gap action programme (mhGAP) intervention guide: updated systematic review on evidence and impact. Evidence Based Mental Health. 2021 doi: 10.1136/ebmental-2021-300254.
    1. Keynejad RC, Dua T, Barbui C, et al. WHO mental health gap action programme (mhGAP) intervention guide: a systematic review of evidence from low and middle-income countries. Evid Based Ment Health. 2018;21:30–34. doi: 10.1136/eb-2017-102750.
    1. Ventevogel P. Integration of mental health into primary healthcare in low-income countries: avoiding medicalization. Int Rev Psychiatry. 2014;26:669–679. doi: 10.3109/09540261.2014.966067.
    1. USP Kenya. The role of peer support in exercising legal capacity. Nairobi: Users and Survivors of Psychiatry in Kenya
    1. Puschner B, Repper J, Mahlke C, et al. Using peer support in developing empowering mental health services (UPSIDES): background, rationale and methodology. Ann Global Health. 2019;85:111. doi: 10.5334/aogh.2435.
    1. Hall C, Baillie D, Atukunda J, et al. Brain Gain in Uganda: A Case Study of Peer Working as an Adjunct to Statutory Mental Health Care in a Low-Income Country. In: White R, Jain S, Orr D, et al., editors. The Palgrave Handbook of Sociocultural Perspectives on Global Mental Health. London: Palgrave Macmillan; 2017. pp. 633–655.
    1. Nixdorf R, Nugent L, Aslam Rh, et al. A multi-national peer support intervention: the UPSIDES pilot phase. Adv Ment Health. 2022;20:2–14. doi: 10.1080/18387357.2021.2020140.
    1. Asher L, Hanlon C, Birhane R, et al. Community-based rehabilitation intervention for people with schizophrenia in Ethiopia (RISE): a 12 month mixed methods pilot study. BMC Psychiatry. 2018;18:250. doi: 10.1186/s12888-018-1818-4.
    1. Asher L, Birhane R, Weiss HA, et al. Community-based rehabilitation intervention for people with schizophrenia in Ethiopia (RISE): results of a 12-month cluster-randomised controlled trial. Lancet Glob Health. 2022 doi: 10.1016/s2214-109x(22)00027-4.
    1. Ohrnberger J, Fichera E, Sutton M, et al. The worse the better? Quantile treatment effects of a conditional cash transfer programme on mental health. Health Policy Plan. 2020;35:1137–1149. doi: 10.1093/heapol/czaa079.
    1. Ssebunnya J, Kigozi F, Lund C, et al. Stakeholder perceptions of mental health stigma and poverty in Uganda. BMC Int Health Hum Rights. 2009;9:5. doi: 10.1186/1472-698X-9-5.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere